Menu

Effects of Autogenic and Reciprocal Inhibition on Trapezitis

Status

Enrolling

Conditions

Neck Pain

Treatments

Other: autogenic inhibition
Other: reciprocal inhibition

Study type

Interventional

Funder types

Other

Identifiers

NCT06086782
REC/RCR & AHS/23/0145

Details and patient eligibility

About

Aim of my study is to compare two techniques of METS i.e., autogenic and reciprocal inhibition techniques on pain, disability and Range of motion among smart phone user with trapezitis.

Full description

Study focuses trapezitis in smart phone users. There are many different causes of neck pain, but one common factor is upper trapezitis. This refers to pain and spasms in the neck caused by inflammation of the trapezius muscle. The aim of this study is to compare the effects of autogenic and reciprocal inhibition techniques on pain, range of motion and disability among smart phone user with trapezitis.

This study will be randomized clinical trial and 40 patients male and female with age 20 to 40 years having NPRS >3 according to inclusion criteria will be included in the study. They will be allocated into 2 groups by non-probability convenience sampling technique. Group A will receive autogenic inhibition technique with conventional physical therapy while Group B will receive reciprocal inhibition technique with conventional therapy. Outcome measures; Neck Disability Index, goniometry and Numeric Pain Rating Scale will measure neck function and neck pain intensity. Total 12 sessions, 3 sessions per week for 4 weeks were provided. Each session was 45 minutes long and measurements will be taken at the baseline and at the end of 4th week. Data will be analyzed by SPSS version 25

Enrollment

42 estimated patients

Sex

All

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mobile phone users age between 20 -40 years old.
  • Both gender male and female included.
  • Neck pain (Numeric Pain Rating Scale >3)
  • With limited Neck ROMs.
  • NDI scoring 15-24points (30-48%) moderate disability

Exclusion criteria

  • Neck pain with whiplash or headache, neurological disorder.
  • History of previous head, neck, cervical spine or shoulder surgery.
  • Infection or inflammatory arthritis in the cervical spine.
  • Trigger point of Upper trapezius will be excluded.
  • History of cervical radiculopathy.
  • Diagnosed fibromyalgia and myopathy.
  • History of cancer.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

42 participants in 2 patient groups

autogenic inhibition
Experimental group
Description:
isometric of muscles and stretching of the same side
Treatment:
Other: autogenic inhibition
reciprocal inhibition
Experimental group
Description:
isometric of muscles and stretching of the opposite side
Treatment:
Other: reciprocal inhibition

Trial contacts and locations

1

There are currently no registered sites for this trial.

Central trial contact

Humera Mubashar, MS

Timeline

Last updated: Oct 17, 2023

Start date

Oct 10, 2023 • 1 year and 6 months ago

End date

Nov 30, 2023 • 1 year and 4 months ago

Today

Apr 29, 2025

Sponsor of this trial

Data sourced from clinicaltrials.gov